文献速递心脑血管急症

冠心病中磁共振灌注与血流储备分数的比较

Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
PubMed 文献 · N Engl J Med · 2019-01-01
一句话结论在稳定型心绞痛且具备冠心病危险因素的患者中,心肌灌注心血管磁共振指导策略在主要不良心脏事件方面不劣于FFR指导策略,且冠脉血运重建率更低。

该不设盲、多中心临床有效性试验随机纳入918例典型心绞痛且具备两个及以上心血管危险因素或运动平板试验阳性的患者,比较心血管磁共振策略与FFR策略。心血管磁共振组心肌缺血至少6%或FFR组FFR≤0.8时推荐血运重建。1年内死亡、非致死性心肌梗死或靶血管血运重建复合主要终点在心血管磁共振组421例中15例(3.6%)、FFR组430例中16例(3.7%),风险差-0.2个百分点(95%CI -2.7至2.4),达到非劣效界值(风险差6个百分点)。心血管磁共振组指数血运重建率低于FFR组(35.7% vs 45.0%,P=0.005),12个月无心绞痛比例两组无显著差异(49.2% vs 43.8%,P=0.21)。

要点

  • 稳定型心绞痛且有两个及以上心血管危险因素或运动平板试验阳性者,心血管磁共振策略在1年主要不良心脏事件上不劣于FFR策略(风险差-0.2个百分点,95%CI -2.7至2.4)。
  • 心血管磁共振组指数血运重建率35.7%(162/454),低于FFR组的45.0%(209/464),P=0.005。
  • 心血管磁共振组符合血运重建推荐标准者40.5%(184/454),FFR组45.9%(213/464),P=0.11。
  • 12个月无心绞痛比例心血管磁共振组49.2%、FFR组43.8%,两组无显著差异(P=0.21)。

适用人群与场景

  • 典型心绞痛且具备两个及以上心血管危险因素或运动平板试验阳性的患者。

诊断标准与关键阈值

  • 心血管磁共振组心肌缺血至少6%时推荐血运重建。
  • FFR组FFR≤0.8时推荐血运重建。

处置流程与药物剂量

  • 随机分配至心血管磁共振策略或FFR策略,按上述缺血阈值或FFR阈值决定是否推荐血运重建。

研究设计与关键结果

  • 不设盲、多中心临床有效性试验随机纳入918例患者,心血管磁共振组454例、FFR组464例。
  • 符合血运重建推荐标准者:心血管磁共振组40.5%(184/454)vs FFR组45.9%(213/464),P=0.11。
  • 指数血运重建:心血管磁共振组35.7%(162/454)vs FFR组45.0%(209/464),P=0.005。
  • 主要复合终点(1年内死亡、非致死性心肌梗死或靶血管血运重建):心血管磁共振组3.6%(15/421)vs FFR组3.7%(16/430),风险差-0.2个百分点(95%CI -2.7至2.4),达到非劣效界值(风险差6个百分点)。
  • 12个月无心绞痛比例:心血管磁共振组49.2% vs FFR组43.8%,P=0.21,无显著差异。

证据类型、等级与局限

  • 证据类型:不设盲、多中心临床有效性试验。
  • 非劣效界值为风险差6个百分点,主要终点结果达到非劣效阈值。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 在稳定型心绞痛且具备冠心病危险因素的患者中,采用心肌灌注心血管磁共振策略指导血运重建,1年主要不良心脏事件不劣于FFR策略,且指数血运重建率更低。
  • 作者认为,心肌灌注心血管磁共振与FFR相比,冠脉血运重建发生率更低,且在主要不良心脏事件方面不劣于FFR。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In patients with stable angina, two strategies are often used to guide revascularization: one involves myocardial-perfusion cardiovascular magnetic resonance imaging (MRI), and the other involves invasive angiography and measurement of fractional flow reserve (FFR). Whether a cardiovascular MRI-based strategy is noninferior to an FFR-based strategy with respect to major adverse cardiac events has not been established.

METHODS: We performed an unblinded, multicenter, clinical-effectiveness trial by randomly assigning 918 patients with typical angina and either two or more cardiovascular risk factors or a positive exercise treadmill test to a cardiovascular MRI-based strategy or an FFR-based strategy. Revascularization was recommended for patients in the cardiovascular-MRI group with ischemia in at least 6% of the myocardium or in the FFR group with an FFR of 0.8 or less. The composite primary outcome was death, nonfatal myocardial infarction, or target-vessel revascularization within 1 year. The noninferiority margin was a risk difference of 6 percentage points.

RESULTS: A total of 184 of 454 patients (40.5%) in the cardiovascular-MRI group and 213 of 464 patients (45.9%) in the FFR group met criteria to recommend revascularization (P = 0.11). Fewer patients in the cardiovascular-MRI group than in the FFR group underwent index revascularization (162 [35.7%] vs. 209 [45.0%], P = 0.005). The primary outcome occurred in 15 of 421 patients (3.6%) in the cardiovascular-MRI group and 16 of 430 patients (3.7%) in the FFR group (risk difference, -0.2 percentage points; 95% confidence interval, -2.7 to 2.4), findings that met the noninferiority threshold. The percentage of patients free from angina at 12 months did not differ significantly between the two groups (49.2% in the cardiovascular-MRI group and 43.8% in the FFR group, P = 0.21).

CONCLUSIONS: Among patients with stable angina and risk factors for coronary artery disease, myocardial-perfusion cardiovascular MRI was associated with a lower incidence of coronary revascularization than FFR and was noninferior to FFR with respect to major adverse cardiac events. (Funded by the Guy's and St. Thomas' Biomedical Research Centre of the National Institute for Health Research and others; MR-INFORM ClinicalTrials.gov number, NCT01236807.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Nagel E, Greenwood JP, McCann GP, et al. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med. 2019. PMID: 31216398. doi:10.1056/NEJMoa1716734

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。